MedPath

Effectiveness of zinc supplementation on the possibility of recurrence of anxiety and depression in opioid dependent patients

Phase 3
Conditions
Patients dependent on opioids.
Opioid related disorders
Registration Number
IRCT20160417027437N3
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
76
Inclusion Criteria

Age 18 to 60 years
Diagnosis of substance abuse disorder based on DSM-V diagnostic criteria
Receiving methadone as the only treatment protocol

Exclusion Criteria

History of allergy to compounds containing zinc
The use of compounds containing zinc and other medicinal supplements before intervention and study
Having harmful thoughts to yourself and others

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety. Timepoint: Before the intervention, one month and three months after the intervention. Method of measurement: Spielberger questionnaire.;Depression. Timepoint: Before the intervention, one month and three months after the intervention. Method of measurement: Beck depression questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath